These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 32644291

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Two-dimensional echocardiographic estimates of left atrial function in healthy dogs and dogs with myxomatous mitral valve disease.
    Dickson D, Caivano D, Matos JN, Summerfield N, Rishniw M.
    J Vet Cardiol; 2017 Dec; 19(6):469-479. PubMed ID: 29111284
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Diagnostic value of vertebral left atrial size as determined from thoracic radiographs for assessment of left atrial size in dogs with myxomatous mitral valve disease.
    Malcolm EL, Visser LC, Phillips KL, Johnson LR.
    J Am Vet Med Assoc; 2018 Oct 15; 253(8):1038-1045. PubMed ID: 30272515
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Dietary intervention reduces left atrial enlargement in dogs with early preclinical myxomatous mitral valve disease: a blinded randomized controlled study in 36 dogs.
    Li Q, Heaney A, Langenfeld-McCoy N, Boler BV, Laflamme DP.
    BMC Vet Res; 2019 Nov 27; 15(1):425. PubMed ID: 31775756
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Echocardiographic evaluation of regurgitant fraction in dogs with subclinical myxomatous mitral valve disease: Method comparison, effects of pimobendan, and reproducibility.
    Ellis-Reis RE, Visser LC, Hsue W, Sharpe AN, Kaplan JL.
    J Vet Cardiol; 2023 Feb 27; 45():27-40. PubMed ID: 36630740
    [Abstract] [Full Text] [Related]

  • 12. Echocardiographic predictors of first onset of atrial fibrillation in dogs with myxomatous mitral valve disease.
    Baron Toaldo M, Mazzoldi C, Romito G, Poser H, Contiero B, Cipone M, Guglielmini C.
    J Vet Intern Med; 2020 Sep 27; 34(5):1787-1793. PubMed ID: 32767718
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Determination of radiographic vertebral heart score and vertebral left atrial size cutoffs based on echocardiographic left atrial size in dogs with myxomatous mitral valve disease.
    Baisan RA, Vulpe V.
    Vet Radiol Ultrasound; 2024 Jan 27; 65(1):54-61. PubMed ID: 38148480
    [Abstract] [Full Text] [Related]

  • 15. Radiographic quantification of left atrial size in dogs with myxomatous mitral valve disease.
    Lam C, Gavaghan BJ, Meyers FE.
    J Vet Intern Med; 2021 Mar 27; 35(2):747-754. PubMed ID: 33634912
    [Abstract] [Full Text] [Related]

  • 16. Echocardiographic parameters for the assessment of congestive heart failure in dogs with myxomatous mitral valve disease and moderate to severe mitral regurgitation.
    Morgan KRS, Monteith G, Raheb S, Colpitts M, Fonfara S.
    Vet J; 2020 Sep 27; 263():105518. PubMed ID: 32928487
    [Abstract] [Full Text] [Related]

  • 17. Volumetric quantification identifies some left atrial dilations undetected by left atrium:aorta ratio measurements: A prospective echocardiographic study in 155 Cavalier King Charles Spaniels with and without degenerative mitral valve disease.
    Chetboul V, Poissonnier C, Foulex P, Alvarado MP, Trehiou-Sechi É, Saponaro V, Passavin P, Desquilbet L.
    PLoS One; 2024 Sep 27; 19(3):e0300827. PubMed ID: 38547236
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.